Skip to NavigationSkip to content

Pharmafile - Manufacturing and Production News

The Scottish Medicines Consortium (SMC) has announced its acceptance of Buvidal (buprenorphine prolonged-release solution for subcutaneous...
A chlamydia vaccine has shown to be safe in a Phase 1 clinical trial, according to a study published in the journal The Lancet Infectious Diseases
Health professionals in the Democratic Republic of Congo (DRC) are now offering two experimental drugs to people infected with Ebola, after they...
The Scottish Medicines Consortium (SMC) has turned down Vertex’ cystic fibrosis drug Orkambi on the grounds that it is not good value for money.
Novartis hid faulty data from FDA over $2.1 million gene therapy Zolgensma Pfizer's sickle cell drug flops at Phase 3 trial Medicare will cover CAR-T...
New Phase 3 data have been revealed on Eli Lilly’s Emgality (galcanezumab-gnlm), detailing its success in meeting all of its primary and secondary...
Britain’s cost-effectiveness body NICE has chosen not to recommend Clovis Oncology’s cancer drug Rubraca (rucaparib).
Takeda has entered into a partnership with Sosei Heptares to develop drugs that modulate G protein-coupled receptor (GPCR) targets.
Sanofi has announced that European Commission (EC) has chosen to extend the marketing approval of its interleukin-4 (IL-4) and interleukin-13 (IL-...
Pfizer has said its sickle cell drug rivipansel failed to meet its primary endpoint or key secondary endpoints in a Phase 3 trial.
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches